# Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

> **NCT01810731** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Centers for Disease Control and Prevention**

## Conditions studied

- Influenza, Human
- HIV
- Malaria
- Tetanus
- Polio

## Interventions

- **BIOLOGICAL:** Quadrivalent Inactivated Influenza Vaccine (QIV)
- **BIOLOGICAL:** Inactivated Polio Vaccine
- **BIOLOGICAL:** Double Dose QIV

## Key facts

- **NCT ID:** NCT01810731
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Scientific review positive from 3 manufacturers; internal committees did not support due to deploying new flu vaccines in HIV+ pregnant women in Kenya.
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01810731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01810731, "Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01810731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*